Yazdani Reza, Hakemi Mazdak Ganjalikhani, Sherkat Roya, Homayouni Vida, Farahani Rahim
Department of Immunology, Faculty of Medicine, Isfahan, Iran.
Cellular and Molecular Immunology Research Center, Isfahan, Iran ; Department of Immunology, Faculty of Medicine, Isfahan, Iran.
Adv Biomed Res. 2014 Jan 9;3:2. doi: 10.4103/2277-9175.124627. eCollection 2014.
Common variable immunodeficfiiency (CVID) is a primary immunodeficiency syndrome representing a heterogeneous set of disorders resulting mostly in antibody deficiency and recurrent infections. However, inflammatory and autoimmune disorders and some kinds of malignancies are frequently reported as a part of the syndrome. Although it is one of the most widespread primary immunodeficiency, only recently some genetic defects in CVID have been identified. Mutations have been detected in inducible T-cell costimulator (ICOS), transmembrane activator and calcium modulator and cyclophilin ligand interactor (TACI), B-cell activating factor-receptor (BAFF-R), B-cell receptor complex (CD19, CD21 and CD81) and CD20. On the other hand, recent studies have shown a decrease in T-helper-17 cells frequency and their characteristic cytokines in CVID patients and this emphasis on the vital role of the T-cells in immunopathogenesis of the CVID. Furthermore, in the context of autoimmune diseases accompanying CVID, interleukin 9 has recently attracted a plenty of considerations. However, the list of defects is expanding as exact immunologic pathways and genetic disorders in CVID are not yet defined. In this review, we have a special focus on the immunopathogenesis of CVID, recent advances in understanding the underlying etiology and genetics for patients.
普通可变免疫缺陷(CVID)是一种原发性免疫缺陷综合征,代表一组异质性疾病,主要导致抗体缺乏和反复感染。然而,炎症性和自身免疫性疾病以及某些类型的恶性肿瘤经常被报告为该综合征的一部分。尽管它是最常见的原发性免疫缺陷之一,但直到最近才发现CVID中的一些基因缺陷。已在诱导性T细胞共刺激分子(ICOS)、跨膜激活剂和钙调蛋白及亲环素配体相互作用分子(TACI)、B细胞活化因子受体(BAFF-R)、B细胞受体复合物(CD19、CD21和CD81)以及CD20中检测到突变。另一方面,最近的研究表明,CVID患者中辅助性T细胞17的频率及其特征性细胞因子有所下降,这突出了T细胞在CVID免疫发病机制中的重要作用。此外,在伴随CVID的自身免疫性疾病背景下,白细胞介素9最近受到了大量关注。然而,由于CVID的确切免疫途径和基因疾病尚未明确,缺陷列表正在不断扩大。在这篇综述中,我们特别关注CVID的免疫发病机制、在理解患者潜在病因和遗传学方面的最新进展。